在人道主义环境中使用家庭防御产品:范围审查
Jacqueline M Lauer1,2, Alexandra DeShaw1,3, Isabelle Ward1
1Department of Health Sciences, Sargent College of Health & Rehabilitation Sciences, Boston University, Boston, Massachusetts, USA.
Maternal & child nutrition
|October 7, 2025
概括
家庭强化产品 (HFP) 在人道主义环境中对幼儿和孕妇/哺乳期妇女显示出可行性. 成功实施需要与现有计划进行整合,并应对改善营养摄入量的后勤挑战.
科学领域:
- 营养科学 营养科学
- 公共卫生 公共卫生
- 人道主义援助 人道主义援助
背景情况:
- 家庭强化产品 (HFPs) 旨在解决关键的营养缺口.
- 关于在人道主义环境中使用HFP存在有限的文档.
- 关注幼儿 (6-59个月) 和孕妇/哺乳期妇女至关重要.
研究的目的:
- 探索在人道主义环境中实施HFP计划的证据基础.
- 评估HFP对危机中的弱势群体的可行性.
- 识别HFP计划成功的促进者和障碍者.
主要方法:
- 电子数据库的范围审查 (PubMed,Embase,CINAHL). 电子数据库的范围审查.
- 对八项选定的研究进行主题分析 (定量,定性,混合方法).
- 在2024年12月进行了搜索,最初产生了70篇文章.
主要成果:
- 在现有的人道主义计划 (粮食分发,增长监测) 中,HFP更可行.
- 坚持,接受,教育和提高意识是成功的关键.
- 物流问题,产品共享和信任障碍阻碍了HFP的使用.
- 健康结果的改善 (生长,贫血) 显示出混合的结果,很难分离出来.
结论:
- 在人道主义环境中实施HFP是可行的,并且可能有好处.
- 需要更多的实施研究和有效性试验.
- 进一步的研究应该澄清在危机中HFP编程的最佳策略.
相关概念视频
Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K
Dose-Response Relationship: Potency and Efficacy
6.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.3K
Clinically Relevant Drug Product Specifications: Methods of Establishment
203
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
203
Dose-Response Relationship: Overview
4.9K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
4.9K


